In silico model development and optimization of in vitro lung cell population growth.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Tissue engineering predominantly relies on trial and error in vitro and ex vivo experiments to develop protocols and bioreactors to generate functional tissues. As an alternative, in silico methods have the potential to significantly reduce the timelines and costs of experimental programs for tissue engineering. In this paper, we propose a methodology to formulate, select, calibrate, and test mathematical models to predict cell population growth as a function of the biochemical environment and to design optimal experimental protocols for model inference of in silico model parameters. We systematically combine methods from the experimental design, mathematical statistics, and optimization literature to develop unique and explainable mathematical models for cell population dynamics. The proposed methodology is applied to the development of this first published model for a population of the airway-relevant bronchio-alveolar epithelial (BEAS-2B) cell line as a function of the concentration of metabolic-related biochemical substrates. The resulting model is a system of ordinary differential equations that predict the temporal dynamics of BEAS-2B cell populations as a function of the initial seeded cell population and the glucose, oxygen, and lactate concentrations in the growth media, using seven parameters rigorously inferred from optimally designed in vitro experiments.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2024 Mostofinejad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      J Tissue Eng. 2019 Feb 22;10:2041731419827922. (PMID: 30834100)
      In Silico Biol. 2019;13(1-2):55-69. (PMID: 31006682)
      Wiley Interdiscip Rev Dev Biol. 2021 Nov;10(6):e399. (PMID: 33145915)
      Toxicol Appl Pharmacol. 2015 Sep 15;287(3):240-5. (PMID: 26091798)
      In Silico Biol. 2019;13(1-2):21-39. (PMID: 30562900)
      Tissue Eng Part A. 2022 Jun;28(11-12):542-554. (PMID: 35345902)
      Sci Rep. 2019 Aug 19;9(1):12034. (PMID: 31427611)
      Adv Drug Deliv Rev. 2020;161-162:90-109. (PMID: 32835746)
      Int J Pharm. 2020 Jul 30;585:119484. (PMID: 32485216)
      J Allergy (Cairo). 2012;2012:943982. (PMID: 22287976)
      Front Bioeng Biotechnol. 2020 Apr 29;8:376. (PMID: 32411692)
      Hypoxia (Auckl). 2015 Sep 18;3:35-43. (PMID: 27774480)
      CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):69-79. (PMID: 27548289)
      Mol Cancer Res. 2023 Jan 3;21(1):36-50. (PMID: 36214668)
      NPJ Regen Med. 2021 Apr 12;6(1):24. (PMID: 33846347)
      Adv Healthc Mater. 2021 Nov;10(21):e2100957. (PMID: 34569180)
      Transpl Int. 2015 Jun;28(6):643-56. (PMID: 24629039)
      J Tissue Eng. 2019 Mar 05;10:2041731419830264. (PMID: 30858965)
      J R Soc Interface. 2020 Mar;17(164):20190801. (PMID: 32208821)
      Biotechnol Rep (Amst). 2014 Dec 08;5:55-62. (PMID: 28626683)
      Nat Cell Biol. 2016 Jul;18(7):803-813. (PMID: 27323329)
      Biomech Model Mechanobiol. 2015 Nov;14(6):1217-25. (PMID: 25804699)
      Cell. 2006 Aug 25;126(4):663-76. (PMID: 16904174)
      Biotechnol Bioeng. 2022 Jul;119(7):1980-1996. (PMID: 35445744)
      Biomech Model Mechanobiol. 2019 Dec;18(6):1965-1977. (PMID: 31201621)
      Sci Rep. 2021 Aug 23;11(1):17028. (PMID: 34426605)
      Comput Methods Programs Biomed. 2007 Oct;88(1):52-61. (PMID: 17707944)
      Toxicol In Vitro. 2010 Feb;24(1):45-55. (PMID: 19755143)
      Biotechnol Bioeng. 2018 Mar;115(3):617-629. (PMID: 29205280)
      J Tissue Eng Regen Med. 2020 May;14(5):653-672. (PMID: 32064791)
      Cancer Res. 1988 Apr 1;48(7):1904-9. (PMID: 2450641)
      Bull Math Biol. 2013 Dec;75(12):2450-73. (PMID: 24154964)
      PLoS One. 2020 Jan 3;15(1):e0227174. (PMID: 31900469)
      Sci Rep. 2021 Jan 13;11(1):1187. (PMID: 33441927)
      Interface Focus. 2016 Apr 6;6(2):20150105. (PMID: 27051516)
      PLoS Comput Biol. 2020 Dec 1;16(12):e1008462. (PMID: 33259472)
      Biomater Sci. 2022 Jan 18;10(2):396-409. (PMID: 34897300)
      Int J Biochem Cell Biol. 2022 May;146:106195. (PMID: 35339913)
      Physiology (Bethesda). 2017 May;32(3):246-260. (PMID: 28404740)
      Mol Cell Endocrinol. 2022 Dec 1;558:111775. (PMID: 36096380)
      Toxicol In Vitro. 2013 Sep;27(6):1719-27. (PMID: 23669205)
      Lab Chip. 2022 Nov 8;22(22):4443-4455. (PMID: 36314259)
      PLoS One. 2018 Aug 27;13(8):e0202079. (PMID: 30148832)
      Tissue Eng Part C Methods. 2012 Aug;18(8):614-23. (PMID: 22332979)
      PLoS Comput Biol. 2023 Sep 29;19(9):e1011515. (PMID: 37773942)
      Biomaterials. 2006 Oct;27(30):5307-14. (PMID: 16797691)
      Biofabrication. 2018 Oct 30;11(1):015002. (PMID: 30270851)
      Chemosphere. 2021 Jan;263:128346. (PMID: 33297271)
      Methods Mol Biol. 2023;2634:87-105. (PMID: 37074575)
      Micromachines (Basel). 2021 Jun 25;12(7):. (PMID: 34202262)
      SIAM Rev Soc Ind Appl Math. 2011 Jan 1;53(1):3-39. (PMID: 21785515)
      J Theor Biol. 2022 Feb 21;535:110998. (PMID: 34973274)
      Brief Bioinform. 2022 Jan 17;23(1):. (PMID: 34619769)
      J Theor Biol. 2015 Feb 7;366:103-14. (PMID: 25433213)
      Bull Math Biol. 2013 Mar;75(3):393-427. (PMID: 23358798)
      Tissue Eng Part C Methods. 2021 Dec;27(12):661-671. (PMID: 34847779)
      BMC Bioinformatics. 2021 Oct 4;22(1):478. (PMID: 34607573)
      Tissue Eng Part C Methods. 2021 Jan;27(1):1-11. (PMID: 33307958)
      Toxicol Sci. 2019 Apr 1;168(2):302-314. (PMID: 30657991)
      Tissue Eng Part C Methods. 2014 Aug;20(8):681-92. (PMID: 24392662)
      Expert Opin Biol Ther. 2014 Oct;14(10):1477-91. (PMID: 25102044)
      Chaos. 2010 Dec;20(4):045105. (PMID: 21198117)
    • Publication Date:
      Date Created: 20240515 Date Completed: 20240515 Latest Revision: 20240518
    • Publication Date:
      20240518
    • Accession Number:
      PMC11095723
    • Accession Number:
      10.1371/journal.pone.0300902
    • Accession Number:
      38748626